Cloron 0.5 mg (Tablet)
Unit Price: ৳ 7.00 (10 x 10: ৳ 700.00)
Strip Price: ৳ 70.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Clonazepam |
| Company | Eskayef pharmaceuticals ltd |
| Also available as |
Title
- Cloron 0.5 mg Tablet
Categories
- Anti-Epileptic Drugs
- Benzodiazepine Hypnotics
Description
- Effective in treating panic disorder
- May be used in the treatment of Lennox-Gastaut Syndrome
- Exhibits anticonvulsive, sedative, muscle relaxing, and anxiolytic effects
- Enhances GABAergic neurotransmission at inhibitory synapses
- Suppresses paroxysmal activity including spike and wave discharge in absence seizures
- Caution required in coadministration with valproic acid
- May increase the incidence of generalized tonic-clonic seizures in certain patient populations
- Caution required in use with patients with open angle glaucoma
- Frequently causes CNS depression
- May lead to drowsiness, ataxia, behavior problems, abnormal eye movements, aphonia, coma, tremor, vertigo, confusion, depression, amnesia, hallucinations, hysteria, increased libido, insomnia, psychosis, and palpitations
- Possible teratogenic effects during pregnancy
- Active ingredient may pass into maternal milk
- Requires special attention in infants and small children
- Greater pharmacologic effects in older patients
- No dose adjustment required in patients with renal impairment
- May have altered pharmacokinetics in patients with hepatic impairment
- Commonly causes drowsiness, ataxia, dysarthria, and nystagmus in overdose cases
- Overdose effects may include areflexia, apnea, hypotension, cardiorespiratory depression, and coma
- Interacts negligibly with phenytoin, carbamazepine, and phenobarbital
- Storage in a dry place away from light and heat, keep out of reach of children
- Molecular Formula: C15H10ClN3O3
Dimensions
- Tablet form
Color options
- White
Functions
- Treatment of panic disorder
- Adjunct in the treatment of Lennox-Gastaut Syndrome
- Anticonvulsive effects
- Sedative effects
- Muscle relaxing effects
- Anxiolytic effects
- Enhancement of GABAergic neurotransmission
- Suppression of paroxysmal activity
- Caution in coadministration with other medications
Materials
- Active ingredient: Clonazepam
Technical specifications
- Initial dose for adults with seizure disorders should not exceed 1.5 mg/day
- Maximum recommended daily dose is 20 mg
- Initial dose for adults with panic disorder is 0.25 mg
- Injection dosage for infants, children, and adults
Design elements
- Chemical Structure: C15H10ClN3O3
Usability features
- Caution in use with patients with open angle glaucoma
- Special attention required in infants and small children
- Greater pharmacologic effects in older patients
- No dose adjustment required in patients with renal impairment
- May have altered pharmacokinetics in patients with hepatic impairment
- Storage instructions: Keep in a dry place away from light and heat, keep out of the reach of children